Hold the Spray Until Morning

Optinose Xhance approved by FDA as first medical therapy for CRS

Positive findings from a repeat dosing study of neffy under nasal allergen challenge conditions will support a potential PDUFA date of October 2, 2024, the company said.

Clinical Focus Business Focus Spotlight TGIF for Optinose Xhance: PDUFA Date Set for Saturday, March 16, 2024 / image credit nasal passages: ©turhanerbas/stock.adobe.com

Best and Worst US Cities for Patients with Seasonal Allergies

Now FDA approved, Optinose’s Xhance is the first nonsurgical option for chronic rhinosinusitis both with and without nasal polyps.

Sydney Jennings

Seasonal Allergy Quiz: 5 Questions on a Budding Problem

The Asthma and Allergy Foundation of America recently released its annual Allergy Capitals™ report. Which cities are most challenging for patients with seasonal allergies?

Vaccination Strategy May Promise Allergy Prevention

What is the optimal duration for immunotherapy? Can intranasal steroids be combined with LRTAs? Test your allergy IQ.

Uptick in Food Allergy Not a Result of Increased Sensitization

An experimental cell-based therapy induces permanent allergen-specific immunologic tolerance to prevent IgE-mediated allergy.

ARS Pharma Submits Response to FDA Complete Response Letter for neffy (epinephrine nasal spray)

Why has the number of food allergies increased but overall sensitization to food allergens remained static?

Related Content

Optinose Xhance approved by FDA as first medical therapy for CRS

Positive findings from a repeat dosing study of neffy under nasal allergen challenge conditions will support a potential PDUFA date of October 2, 2024, the company said.

Best and Worst US Cities for Patients with Seasonal Allergies

Now FDA approved, Optinose’s Xhance is the first nonsurgical option for chronic rhinosinusitis both with and without nasal polyps.

Sydney Jennings

Seasonal Allergy Quiz: 5 Questions on a Budding Problem

The Asthma and Allergy Foundation of America recently released its annual Allergy Capitals™ report. Which cities are most challenging for patients with seasonal allergies?

Vaccination Strategy May Promise Allergy Prevention

What is the optimal duration for immunotherapy? Can intranasal steroids be combined with LRTAs? Test your allergy IQ.

Uptick in Food Allergy Not a Result of Increased Sensitization

An experimental cell-based therapy induces permanent allergen-specific immunologic tolerance to prevent IgE-mediated allergy.